The present invention aims to provide a sweetness receptor antagonist useful for the prophylaxis or treatment of metabolic syndrome, diabetes, obesity and the like. A sweetness receptor antagonist containing a compound represented by the formula (I)wherein each symbol is as described in the DESCRIPTION, or a salt thereof.